Original

Inpatient rehabilitation of working-age adults with ischemic stroke: comparing men and women clinical and functional characteristics at admission and predicting functionality

A. García-Rudolph, S. Laxe, B. Cegarra, J. Saurí-Ruiz, E. Opisso, J.M. Tormos, M. Bernabeu [REV NEUROL 2022;74:69-77] PMID: 35084731 DOI: https://doi.org/10.33588/rn.7403.2021297 OPEN ACCESS
Volumen 74 | Number 03 | Nº of views of the article 6.383 | Nº of PDF downloads 139 | Article publication date 01/02/2022
Icono-PDF-OFF Download PDF Castellano Icono-PDF-OFF Download PDF English students-cap copy Acceder a Formación Citation Search in PubMed
Share in: Facebook Twitter
Go to another issue
ABSTRACT Artículo en español English version
INTRODUCTION The role of gender in functional independence for activities of daily living after ischemic stroke is still controversial. We aim to a) compare clinical characteristics of men and women at inpatient rehabilitation admission b) compare their functional independence at admission and discharge c) identify predictors of functional independence.

MATERIALS AND METHODS Retrospective observational cohort study. State-of-the-art variables were used for admission and discharge comparisons and to predict total FIM (Functional Independence Measure) at discharge, FIM gain, FIM efficiency and FIM effectiveness using multivariate linear regressions.

RESULTS 144 patients (33% women) admitted to inpatient rehabilitation in a Spanish specialized center, with less than 3 weeks since ischemic stroke onset were included. Men were older (p = 0.039), 19.6% of men had diabetes mellitus (6.4% of women) (p = 0.038), with 52.6% of men being non-smokers (72.3% of women) (p = 0.022). No significant differences were observed in FIM at admission, discharge, FIM gain, efficiency or effectiveness (total, motor either cognitive FIM). Regression analysis identified sex (ß = –0.13), stroke severity (ß = –0.25) and admission total FIM (ß = –0.69) as significant predictors of total FIM gain (R2 = 0.42). The same variables predicted discharge total FIM: sex (ß = –0.12), severity (ß = –0.23) and admission total FIM (ß = 0.59) (R2 = 0.51). FIM efficiency was predicted by admission total FIM (ß = –0.64), severity (ß = –0.24), age (ß = –0.17) and length of stay (ß = –0.45) (R2 = 39.9%). FIM effectiveness model explained only 13.5% of the variance.

CONCLUSIONS No functional differences between men and women in any independence measure were found. Sex was a significant predictor but leaving half of the variance unexplained.
KeywordsActivities of daily livingBrain ischemiaGenderRehabilitationSexStroke CategoriesPatología vascularTécnicas exploratorias
FULL TEXT Artículo en español English version

Introduction


Stroke is the main cause of long-term disability in Western society [1]. Recent publications are increasingly recognizing differences between women and men in relation to stroke. For example, each year, approximately 55,000 more women than men have a stroke with a higher lifetime risk (attributed to women’s higher life expectancy) [2], women have more severe strokes [3], symptoms at onset are more often non-specific in women [4], the time interval between symptoms onset and both the presentation to hospital and the beginning of treatment is longer in women than in men [5]. Evidence increasingly shows that risk factors for stroke differ between men and women: male patients are more likely to smoke [6] and have cardiovascular disease [7], whereas women are older at the time of stroke onset, rates of hypertension and atrial fibrillation are higher in women than in men [5], meanwhile rates of diabetes mellitus are lower in women than in men [8], nevertheless it has been recently reported that the excess risk of stroke from diabetes mellitus is higher in women than in men [9]. Related research also suggests that abdominal obesity has a stronger effect on stroke risk among women than men [10] as well as depression [4].

Therefore, understanding sex differences at rehabilitation admission and outcomes, considering treatment efficiency and effectiveness, is important since could provide evidence for reducing potential sex disparities [11]. Despite the growing body of knowledge in many stroke fields, the existing literature on the role of gender in functional recovery after stroke rehabilitation is limited and still controversial. Some reports have shown no differences in functional outcome between men and women [12-16] some have reported better functional outcome in men [17-19], while others point to better recovery in women [20].

Functional independence has been previously reported from a sex perspective in Spanish population, Roquer et al [21] (n = 1581) reported women to be on average, 6 years older than men, had a longer hospital stay and remained more disabled than men. Mean age in men was 74.6 ± 11.4 and in women was 68.8 ± 11.9. Vázquez-Guimaraens et al [22] (n = 365) included sex as independent predictor of functional independence at discharge, being admission functional independence the only significant predictor. The mean age of all included patients was 66.8 ± 12.0. Murie-Fernández et al [23] (n = 143) reported age, sex and stroke severity as significant predictors of functional outcome in their multivariate regressions. Mean age was 64.9 ± 13.8. Moreno-Palacios et al [24] (n = 231) included sex as prognostic factor but was found non-significant. Mean age was 74.26 ± 13.1.

Preliminary data screening performed in our sample led us to hypothesize that the mean age in our included patients would be younger than in previous (national and international) research and the inclusion of scarcely reported factors may contribute to the existing literature.

In this study we propose a) to compare men and women at inpatient rehabilitation admission using variables identified in previous research, such as stroke severity, age, hemiparesis, further extending them with specific clinical factors (diabetes, atrial fibrillation, dysphagia, body mass index and depression) to add to limited data on these variables in Spanish population with first time ischemic stroke, admitted to rehabilitation within 3 weeks since onset to rehabilitation admission b) compare men and women functionality at admission and discharge, and c) analyze sex as predictor of functionality at discharge.
 

Materials and methods


Study design


A retrospective observational cohort study enrolling patients with first time ischemic stroke admitted to the rehabilitation unit of the acquired brain injury department of the Institut Guttmann-Hospital de Rehabilitació in Barcelona (Spain) was conducted following the STROBE Guidelines [25]. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Participants and setting


Eligible participants were adult patients (≥ 18 years at the moment of admission, no other age restriction was imposed to participants) with the diagnosis of first-time ischemic stroke, receiving inpatient rehabilitation between September 2014 and December 2020.

Patients were excluded for the following reasons: major musculoskeletal problems, more than 3 weeks of the onset of symptoms since admission to inpatient rehabilitation, cases of transient ischemic attack or subarachnoid hemorrhage, diagnosis of stroke in the context of another concomitant comorbidity (e.g., traumatic brain injury) and a previous history of another disabling condition.

Functional assessments


The Functional Independence Measure (FIM) [26] and the Barthel Index (BI) [27] were used as functional assessments (though BI was only used at admission). These measures are routinely administered within 24 hours after inpatient admission by trained and certified evaluators of the physical medicine and rehabilitation unit.

FIM gain was defined as the difference between FIM at admission and FIM at discharge. FIM efficiency was defined as FIM gain divided by length of stay (LOS) and FIM effectiveness as: (final score-initial score) / (maximum score-initial score) × 100 [28].

In order to classify patients at admission according to their functionality, we followed the quality-based procedures (QBPs) [29] where severity-specific rehabilitation patient groups (RPGs) were identified using cognitive FIM, motor FIM and age [30].

Clinical variables


The following data was abstracted from the hospital’s electronical health records (EHRs): demographics (such as age, sex, education and marital status); stroke severity, using the National Institutes of Health Stroke Scale (NIHSS) and the location of stroke, classified using the Oxfordshire Community Stroke Project [31] as total anterior circulation infarcts (TACI), partial anterior circulation infarcts (PACI), lacunar circulation infarcts (LACI) and posterior circulation infarcts (POCI). Stroke related risk factors, comorbidities and medical complications, such as diabetes, dysphagia, depression, hypertension, body mass index (BMI), smoking habits and atrial fibrillation, reported in EHRs using ICD9 codes were also collected.

Rehabilitation program


All patients admitted at the rehabilitation unit are referred from different acute care setting hospitals and fulfill the hospital criteria for admission which include SMART (specific, measurable, achievable, relevant and time-bound) objectives and social support for discharge in case of severe disability. The rehabilitation program includes five hours of intensive treatment oriented towards cognitive, swallowing, behavioral and physical problems as well as training in activities of daily life living. Variables related to the rehabilitation program such as the time in between onset of stroke and initiation of the rehabilitation program –time since onset to admission (days)– and length of stay (LOS) were also reported.

Statistical analyses


All statistical analyses were performed in R-v3.5.1 (64 bits), level of significance was set at p = 0.05. Patients were stratified into two groups (women and men). Descriptive statistics were used for demographic and clinical characteristics of participants as well as functional assessments. The two groups were compared using the c2 test for categorical variables and the Kruskal-Wallis test for continuous and ordered variables.

Associations with FIM were examined among the potential predictor variables using multivariate regression analyses. All variables were submitted to the multivariate analysis using the all-subsets method in order to maximize R2 and adjusted R2 performing an exhaustive search (forward and backward stepwise) using the leaps R package [32]. Categorical variables were dichotomized (yes = 1, no = 0; woman = 1, man = 0; current smoker and former smoker = 1 and nonsmoker = 0; less than 12 years of education = 0, more than 12 years of education = 1).

Multicollinearity of independent variables is tested by the variance inflation factor (VIF) and the tolerance (1/VIF). Tolerance is associated with each independent variable and ranges from 0 to 1. A tolerance below 0.40 and/or a VIF of 5 and above indicates a multicollinearity problem [33].

The assumption of independent errors is evaluated using the Durbin-Watson. The closer to 2 that the value is, the better. As a conservative rule it is suggested that for values less than 1 or greater than 3 the assumption of independence is not met [33].

The dependent variables in multivariate regressions were: total FIM gain, total FIM efficiency, total FIM effectiveness and total FIM at discharge.
 

Results


The source sample was the total number of ischemic stroke patients admitted to the rehabilitation unit of the acquired brain injury department of the hospital during the whole period under study (September 2014 to December 2020). Patients’ selection flowchart is detailed in the figure.

 

Figure. Patients’ selection flowchart.






 

A total of 1,166 records were identified through database searching for adult patients with primary diagnosis of ischemic stroke without previous history of another disabling condition. After removing n = 637 patients with more than 3 weeks since stroke onset to rehabilitation admission, n = 211 patients with missing FIM at admission and 174 with missing FIM at discharge, there were 144 patients left to include in the analysis.

Table I presents patients characteristics at admission, 67.3% of all participants were men and 32.7% women. The median age was 50.11 (53.11 for men and 46.18 for women), being women significantly younger (p = 0.039) (mean age was 51.20 ± 7.48 for men and 47.87 ± 9.70 for women), all 144 patients were at their working-age.

 

 

Table I. Characteristics at admission for men and women.

 

Men
(n = 97)

Women 
(n = 47)

p


Age at admission in years

51.20 (7.48)

47.87 (9.7)

0.039


Age Ranges at admission, %

0.004


   19-34

3.1

4.3


   35-44

14.4

40.4


   45-54

45.4

25.5


   55-64

37.1

29.8


OCSP classification at admission, %

0.149


   LACI

3.2

2.2


   POCI

8.4

4.3


   TACI

75.8

78.3


   PACI

11.6

6.5


NIHSS at admission

13.36 (5.66)

13.38 (4.31)

0.988


NIHSS stratification at admission,%

0.038


   Mild

22.7

12.8


   Moderate

39.2

61.7


   Severe

38.1

25.5


RPG at admission, %

0.672


   1100

50.5

57.4


   1120

23.7

25.5


   1130

9.3

6.4


   1140

3.1

2.1


   1150

8.2

8.5


   1160

5.2

0


RPG stratification at admission, %

0.617


   Mild-RPG

13.4

8.5


   Moderate-RPG

36.1

34


   Severe-RPG

50.5

57.4


Time since onset to admission in days

20.11 (6.25)

19.32 (6.2)

0.34


BMI at admission

25.75 (3.73)

25.19 (3.99)

0.385


BMI at discharge

25.38 (3.46)

24.74 (3.82)

0.322


BMI (Discharge – Admission)

–0.36 (2)

–0.45 (1.45)

0.929


Smoking habits, %

0.022


   Current smoker

32

25.5


   Former smoker

15.5

2.1


   Nonsmoker

52.6

72.3


Hypertension, %

45.4

29.8

0.074


Hemiparesis, %

0.335


   Left

24.7

29.8


   No

1

4.3


   Right

74.2

66


Dysphagia, %

39.2

25.5

0.107


Aphasia, %

43.3

48.9

0.524


Depression medication at admission, %

60.8

68.1

0.397


Diabetes, %

19.6

6.4

0.038


Atrial fibrillation, %

3.1

4.3

0.721


Educational level, %

0.382


   Illiterate

4.2

0


   Read and write (≤1 years)

3.1

4.5


   Primary (2-6 years)

47.9

38.6


   Secondary (7-12 years)

26

38.6


   Higher (≥13 years)

18.8

18.2


   Missings

1

3


Marital status, %

0.625


   Married

70.5

61.7


   Divorced

8

6.4


   Separated

4.5

6.4


   Single

17

25.5


Length of stay in rehabilitation in days

63.27 (22.81)

68.49 (26.02)

0.214


All characteristics are presented as mean (SD) unless otherwise indicated (e.g., %). BMI: body mass index; LACI: lacunar infarcts; NIHSS: National Institutes of Health Stroke Scale; OCSP: Oxfordshire Community Stroke Project; PACI: partial anterior circulation infarcts; POCI: posterior circulation infarcts; RPG: rehabilitation patient group; SD: standard deviation; TACI: total anterior circulation infarcts.
Note: the RPG range from 1100 to 1160, where a lower number indicates greater severity. The RPG assigned to each patient was used to classify stroke severity as mild, moderate, or severe as follows: mild-RPG: 1150, 1160; moderate-RPG: 1120, 1130, 1140 and severe-RPG:1100, 1110.

 

When stratifying by age groups, in women the largest proportion of participants was aged 35-44 (40.4%) meanwhile in men only 14.4%.  The largest proportion of men was aged 45-54 (45.4% of participants) meanwhile in women only 25.5% (p = 0.004). No significant differences were found in NIHSS total score.

The proportion of men with diabetes was significantly higher: 19.6% men had type II diabetes meanwhile only 6.4% in women (p = 0.038).

Functional assessments 


Regarding functional assessments, as reported in table II, no significant differences were observed in FIM at admission, either at discharge, when considering total FIM, motor or cognitive subtests. Similarly, no significant differences were observed in relation to FIM gain, efficiency or effectiveness when considering total, motor either cognitive FIM subtests.

 

Table II. Functional assessments at admission and discharge.

 

Men
(n = 97)

Women
(n = 47)

p


T-FIM at admission

58.88 (25.33)

59.27 (24.5)

0.885


C- FIM at admission

20.5 (9.74)

22.59 (9.61)

0.262


M-FIM at admission

38.38 (19.64)

36.68 (17.99)

0.602


BI at admission

32.37 (21.76)

33.29 (21.47)

0.806


T-FIM at discharge

93.51 (20.25)

90.63 (20.68)

0.4


C- FIM at discharge

25.83 (8.36)

26.66 (7.71)

0.719


M-FIM at discharge

67.68 (14.9)

63.98 (16.65)

0.217


T-FIM Gain

34.63 (19.23)

31.36 (17.54)

0.356


C- FIM Gain

5.33 (5.58)

4.06 (4.86)

0.171


M-FIM Gain

29.29 (16.39)

27.29 (15.31)

0.603


T-FIM Efficiency median (P25-P75)

0.53 (0.35-0.7)

0.48 (0.26-0.68)

0.284


T-FIM Efficiency mean (SD)

0.56 (0.32)

0.5 (0.31)


C-FIM Efficiency median (P25-P75)

0.07 (0.01-0.12)

0.04 (0-0.09)

0.1


C-FIM Efficiency mean (SD)

0.08 (0.08)

0.06 (0.07)


M-FIM Efficiency median (P25-P75)

0.45 (0.3-0.61)

0.44 (0.26-0.6)

0.509


M-FIM Efficiency mean (SD)

0.48 (0.28)

0.44 (0.28)


T-FIM Effectiveness median (P25-P75)

53.96 (38.09-67.85)

50.00 (34.7-60.8)

0.246


T-FIM Effectiveness mean (SD)

52.27 (22.51)

47.42 (21.3)


C-FIM Effectiveness median (P25-P75)

31.81 (4.76-60)

27.27 (0-45)

0.142


C-FIM Effectiveness mean (SD)

37.94 (33.64)

27.65 (35.32)


M-FIM Effectiveness median (P25-P75)

57.14 (36.84-71.93)

55.86 (38.4-65.42)

0.365


M-FIM Effectiveness mean (SD)

55.07 (23.31)

50.62 (23.19)


BI: Barthel index; C-FIM: cognitive FIM; FIM: Functional independence measure; FIM gain: FIM at discharge – FIM at admission; FIM efficiency: FIM gain divided by length of stay; FIM Effectiveness: (final score – initial score) / (maximum score-initial score) × 100; T-FIM: total FIM; M-FIM: motor FIM; T-FIM: M-FIM + C-FIM.

 

Multivariant analysis


Significant predictors of total FIM gain (Table III, model 1) are total FIM at admission (β = –0.69, p < 0.0001), NIHSS (β = –0.92, p = 0.029) and sex (β = –0.13, p = 0.039), explaining 42.02% of the variance.

 

Table III. Multivariate linear regressions. non-standard β. 95% CIs. standard β. VIF. R2 and adjusted R2.
 
Variables

β (95% CI)

Std β

VIF

Tol

p

R2

Adj R2

10FCVR10

1

TFIM gain


Hemiparesis

–3.21(–8.54. 2.12)

–0.07

1.05

0.95

0.235

0.4567

0.4202

0.4198


Depression

3.65 (–1.58. 8.9)

0.09

1.16

0.85

0.17


Diabetes

–6.39 (–13.16. 0.37)

–0.12

1.07

0.92

0.063


TFIM adm

–0.51 (–0.64. –0.39)

–0.69

1.70

0.58

<0.001


LOS

0.08 (–0.02. 0.19)

0.107

1.29

0.77

0.139


Gender. Woman

–5.55 (–10.83. –0.27)

–0.13

1.11

0.89

0.0395


NIHSS

–0.92 (–1.45. –0.38)

–0.25

1.4

0.7

< 0.001


Hypertension

–2.8 (–7.97. 2.36)

–0.07

1.16

0.85

0.285


Age adm

–0.23 (–0.54. 0.06)

–0.1

1.18

0.84

0.128


Durbin test

D-W = 2.29; p = 0.07


2

TFIM Dis

Hemiparesis

–3.21 (–8.54. 2.12)

–0.07

1.05

0.95

0.23

0.5419

0.5112

0.5102


Depression

3.65 (–1.58. 8.9)

–0.07

1.16

0.85

0.17


Diabetes

–6.39 (–13.16. 0.37)

–0.11

1.07

0.92

0.063


TFIM adm

0.48 ( 0.35. 0.6)

0.59

1.70

0.58

<0.001


LOS

0.08 (–0.02. 0.19)

0.09

1.29

0.77

0.139


Gender. Woman

–5.55 (–10.83. –0.27)

–0.12

1.11

0.89

0.0395


NIHSS

–0.92 (–1.45. –0.38)

–0.23

1.4

0.71

<0.001


Hypertension

–2.8 (–7.97. 2.36)

–0.06

1.16

0.86

0.285


Age adm

–0.23 (–0.54. 0.06)

–0.09

1.18

0.84

0.128


Durbin test

D-W = 2.2; p = 0.074


3

TFIM Effi

Hemiparesis

–3.4 (–13.01. 6.2)

–0.04

1.05

0.95

0.484

0.399

0.359

0.351


Depression

7.5 (–1.94. 16.96)

0.11

1.16

0.85

0.118


Diabetes

–8.04 (–20.24. 4.14)

–0.09

1.07

0.92

0.194


TFIM adm

–0.83 (–1.05. –0.6)

–0.64

1.7

0.58

<0.001


LOS

–0.6 (–0.8. –0.4)

–0.45

1.29

0.77

<0.001


Gender. Woman

–6.41 (–15.93. 3.11)

–0.09

1.11

0.89

0.185


NIHSS

–1.51 (–2.47. –0.55)

–0.24

1.4

0.7

0.002


Hypertension

–3.69 (–13.01. 5.61)

–0.05

1.16

0.85

0.433


Age adm

–0.65 (–1.2. –0.1)

–0.17

1.18

0.84

0.02


Durbin test

D-W = 2; p = 0.792


4

TFIM Effe

Hemiparesis

–2.94 (–10.94. 5.05)

–0.06

1.05

0.95

0.467

0.135

0.114

0.121


Depression

4.45 (–3.41. 12.33)

0.09

1.16

0.85

0.264


Diabetes

–9.02 (–19.17. 1.12)

–0.14

1.07

0.92

0.08


TFIM adm

–0.04 (–0.23. 0.13)

–0.05

1.7

0.58

0.598


LOS

0.08 (–0.08. 0.25)

0.09

1.29

0.77

0.321


Gender. Woman

–7.96 (–15.89. –0.03)

–0.16

1.11

0.89

0.049


NIHSS

–1.3 (–2.1. –0.51)

–0.31

1.4

0.7

0.001


Hypertension

–3.22 (–10.97. 4.53)

–0.07

1.16

0.85

0.412


Age adm

–0.28 (–0.74. 0.174)

–0.1

1.18

0.84

0.222


Durbin test

D-W = 2.11; p = 0.694


NIHSS: National Institutes of Health Stroke Scale, FIM: Functional independence measure; TFIM: total FIM, LOS: Length of stay; 10FCVR10: 10-fold cross validation repeated 10 times. In bold, significant variables.

 

In relation to total FIM at discharge, model 2 identifies total FIM at admission (β = 0.59, p < 0.0001), NIHSS (β = –0.92, p < 0.0001) and sex (β = –0.12, p = 0.0395), explaining 51.12% of the variance.

In relation to total FIM efficiency, model 3 identifies total FIM at admission (β = –0.64, p < 0.0001), LOS (β = –0.45, p < 0.001) NIHSS (β = –0.24, p = 0.002) and age at admission (β= –0.17, p = 0.02), explaining 39.9% of the variance.

Regarding total FIM effectiveness, model 4 identifies NIHSS (β = –0.31, p = 0.001) and sex (β = –0.16, p = 0.049), explaining only 13.50% of the variance.
 

Discussion


This study compared inpatient rehabilitation admission characteristics and functionality of adults with ischemic stroke, from a sex perspective. Results confirmed our hypothesis about the young age of our participants; in fact, all included patients turned to be at their working-age (when this was not an inclusion criteria).

One of the findings that caught the attention of the authors was the low proportion of included women (67% men and 33% women). This does not seem to be only explained by age [34-35]. Literature on the subject has already detected that women after stroke tend to receive fewer specialized rehabilitation than men [36]. In an European Concerted Action involving 7 countries (Spain was one of them), (n = 4499) being woman and not stroke severity, was reported to be a major discriminating factor for the use of diagnostic resources or therapeutic interventions [37]. Several previous studies have already indicated that recommended treatments were administered less often to women suffering myocardial infarction [38-40]. Key treatments such as intravenous thrombolysis was reported as less likely to be offered to older women than to members of other demographics [41]. Women are less likely than men to be sent to specialized centers for large vessel occlusion acute ischemic stroke as recently reported [42].

In our scenario we could not control the gender ratio in the admitted patients or if there was a gender bias in the referral from acute treatment units.  When compared to similar studies in Spanish population, mixed results are found, for example Roquer et al [21] reported 51.7% men, Vázquez-Guimaraens et al [22] 62.19%, Murie-Fernández et al [23] 50.8% and Moreno-Palacios et al [24] 55.4%. Nevertheless, we did not conduct an exhaustive search of related studies, leaving this as future research.

Our results confirm previous reports in relation to the rates of diabetes mellitus being significantly lower in women than in men [8]. The prevalence of type 2 diabetes mellitus increases with age [43] in our sample women are significantly younger, furthermore the largest proportion of women participants is in the 35-44 range whereas it is 45-54 for men.

In relation to functionality no significant differences between men and women were observed (in FIM at admission, either at discharge, when considering total, motor or cognitive FIM, FIM gain, efficiency or effectiveness when considering total, motor either cognitive FIM) adding to similar previous recent results [13-15]. Nevertheless, our population is remarkably younger. Norlander et al [13] reported median age was 75 (28–97) in women and 78 (55–96) in men; Hay et al [14] mean age was 76.7 ± 10.1 in women and 74.8 ± 9.8 in men and MacDonald et al [15] reported 80% of participants being older than 70 years old. Furthermore, as recently reported, associations between factors for ischemic stroke and clinical outcomes have been analyzed predominantly in older rather than younger patients [44].

In our multivariate regression analysis, sex was a significant predictor of total FIM at discharge and total FIM gain, being the third most important predictor in both cases (after total FIM assessment at admission and NIHSS), these results are similar to the EPICA study in Spanish population [23].

Study limitations


The data for this study was collected in a single monographic rehabilitation hospital, suggesting that the generalization of these results should be considered carefully.

It is recommended to predict for a specific subsequent time point rather than the expected outcome at discharge [45]. It is our aim to analyze functional outcomes from a gender perspective at specific time points in future work. Several known predictive factors for functional independence in stroke were not included in this study (such as white matter [46], fatigue [47] or visuospatial inattention [48]) which could probably have increased the models’ explained variance. Finally, a large number of patients with ischemic stroke were not eligible for this study, as detailed in Figure 1, nevertheless, the proportion of men and women (as well as their age) was similar in those included and excluded.
 

Conclusions


We were not able to detect any impact of sex on the functional assessments of adult patients admitted to a specialized care rehabilitation center after sustaining an ischemic stroke. Nevertheless, being a woman was found as significant predictor of total FIM at discharge, total FIM gain and total FIM effectiveness. All included patients were younger than 65 years, though this was not an inclusion criterion, therefore our findings add to the scarce literature reporting on working-age participants. Our sample showed a clear predominance of men (67%), in line with previous and recent related publications. Do women with stroke have less opportunities for being admitted in a rehabilitation program? This question still remains to be answered and highlights the importance of future related research.

 

References


 1. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 2020; 141: e139-596.

 2. Poggesi A, Insalata G, Papi G, Rinnoci V, Donnini I, Martini M, et al. Gender differences in post-stroke functional outcome at discharge from an intensive rehabilitation hospital. Eur J Neurol 2021; 28: 1601-8.

 3. Dehlendorff C, Andersen KK, Olsen TS. Sex disparities in stroke: women have more severe strokes but better survival than men. J Am Heart Assoc 2015; 4: e001967.

 4. Bushnell C, Howard VJ, Lisabeth L, Caso V, Gall S, Kleindorfer D, et al. Sex differences in the evaluation and treatment of acute ischaemic stroke. Lancet Neurol 2018; 17: 641-50.

 5. Cordonnier C, Sprigg N, Sandset EC, Pavlovic A, Sunnerhagen KS, Caso V, et al. Stroke in women –from evidence to inequalities. Nat Rev Neurol 2017; 13: 521-32.

 6. Peters SA, Huxley RR, Woodward M. Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank study. BMJ Open 2014; 4: e005663.

 7. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, et al; investigators of the Registry of the Canadian Stroke Network. Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005; 36: 809-14.

 8. Ullberg T, Zia E, Petersson J, Norrving B. Changes in functional outcome over the first year after stroke: an observational study from the Swedish stroke register. Stroke 2015; 46: 389-94.

 9. Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet 2014; 383: 1973-80.

 10. Rodríguez-Campello A, Jiménez-Conde J, Ois Á, Cuadrado-Godia E, Giralt-Steinhauer E, Vivanco RM, et al. Sex-related differences in abdominal obesity impact on ischemic stroke risk. Eur J Neurol 2017; 24: 397-403.

 11. Scrutinio D, Battista P, Guida P, Lanzillo B, Tortelli R. Sex differences in long-term mortality and functional outcome after rehabilitation in patients with severe stroke. Front. Neurol 2020; 11: 84.

 12. Bassi A, Colivicchi F, Santini M, Caltagirone C. Gender-specific predictors of functional outcome after stroke rehabilitation: Potential role of the autonomic nervous system. European Neurology 2010; 63: 279-84.

 13. Norlander A, Jönsson AC, Ståhl A, Lindgren A, Iwarsson S. Activity among long-term stroke survivors. A study based on an ICF oriented analysis of two established ADL and social activity instruments. Disabil Rehabil 2016; 38: 2028-37.

 14. Hay CC, Graham JE, Pappadis MR, Sander AM, Hong I, Reistetter TA. The impact of one’s sex and social living situation on rehabilitation outcomes after a stroke. Am J Phys Med Rehabil 2020; 99: 48-55.

 15. MacDonald SL, Hall RE, Bell CM, Cronin S, Jaglal SB. Sex differences in the outcomes of adults admitted to inpatient rehabilitation after stroke. PM R 2021; [Epub ahead of print].

 16. Tanlaka E, King-Shier K, Green T, Seneviratne C, Dukelow S. Sex differences in stroke rehabilitation care in Alberta. Can J Neurol Sci 2020; 47: 494-503.

 17. Paolucci S, Bragoni M, Coiro P, De Angelis D, Fusco FR, Morelli D, et al. Is sex a prognostic factor in stroke rehabilitation? A matched comparison. Stroke 2006; 37: 2989-94.

 18. Liljehult MM, von Euler-Chelpin MC, Christensen T, Buus L, Stokholm J, Rosthøj S. Sex differences in independence in activities of daily living early in stroke rehabilitation. Brain Behav 2021 [Epub ahead of print].

 19. Gargano JW, Reeves MJ. Sex differences in stroke recovery and stroke-specific quality of life: Results from a statewide stroke registry. Stroke 2007; 38: 2541-8.

 20. O’Brien SR, Xue Y. Predicting goal achievement during stroke rehabilitation for Medicare beneficiaries. Disabil Rehabil 2014; 36: 1273-8.

 21. Roquer J, Campello AR, Gomis M. Sex differences in first-ever acute stroke. Stroke 2003; 34: 1581-5.

 22. Vázquez-Guimaraens M, Caamaño-Ponte JL, Seoane-Pillado T, Cudeiro J. Factors related to greater functional recovery after suffering a stroke. Brain Sci 2021; 11: 802.

 23. Murie-Fernández M, Marzo MM. Predictors of neurological and functional recovery in patients with moderate to severe ischemic stroke: the EPICA study. Stroke Res Treat 2020; 2020: 1419720.

 24. Moreno-Palacios JA, Moreno-Martínez I, Bartolomé-Nogues A, López-Blanco E, Juárez-Fernández R, García-Delgado I. Factores pronósticos de recuperación funcional del ictus al año. Rev Neurol 2017; 64: 55-62.

 25. STROBE Strengthening the reporting of observational studies in epidemiology. URL: https: //strobe-statement.org/index.php?id=available-checklists. Fecha última consulta: 22.08.2021.

 26. Granger CV, Hamilton BB, Zielezny M, Sherwin FS. Advances in functional assessment in medical rehabilitation. Topics in Geriatric Rehabilitation 1986; 1: 59-74.

 27. Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud 1988; 10: 64-7.

 28. Tokunaga M, Higashi T, Inoue R, Ohkubo T, Watanabe S. Comparison of Functional Independence Measure (FIM) gain between groups with extreme differences in FIM score at admission. Int J Phys Med Rehabil 2017; 5: 402.

 29. Health Quality Ontario; Ministry of Health and Long-Term Care. Quality-based procedures: clinical handbook for stroke (acute and postacute). Toronto: Health Quality Ontario; 2016.

 30. Lai W, Buttineau M, Harvey JK, Pucci RA, Wong APM, Dell’Erario L, et al. Clinical and psychosocial predictors of exceeding target length of stay during inpatient stroke rehabilitation. Top Stroke Rehabil 2017; 24: 510-6.

 31. Asdaghi N, Jeerakathil T, Hameed B, Saini M, McCombe JA, Shuaib A, et al. Oxfordshire community stroke project classification poorly differentiates small cortical and subcortical infarcts. Stroke 2011; 42: 2143-8.

 32. Lumley T. Regression subset selection. URL: https: //cran.r-project.org/web/packages/leaps/leaps.pdf. [22.08.2021].

 33. O’Brien RM. A caution regarding rules of thumb for variance inflation factors. quality & quantity. 2007; 41: 673-90.

 34. Gibson CL. Cerebral ischemic stroke: is gender important? J Cereb Blood Flow Metab 2013; 33: 1355-61.

 35. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke 2009; 40: 1032-7.

 36. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008; 7: 915-26.

 37. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, et al; European BIOMED Study of Stroke Care Group. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003; 34: 1114-9.

 38. Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000; 343: 8-15.

 39. Miller TD, Roger VL, Hodge DO, Hopfenspirger MR, Bailey KR, Gibbons RJ. Gender differences and temporal trends in clinical characteristics, stress test results and use of invasive procedures in patients undergoing evaluation for coronary artery disease. J Am Coll Cardiol 2001; 38: 690-7.

 40. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217-25.

 41. Fredwall M, Sternberg S, Blackhurst D, Lee A, Leacock R, Nathaniel TI. Gender differences in exclusion criteria for recombinant tissue-type plasminogen activator. J Stroke Cerebrovasc Dis 2016; 25: 2569-74.

 42. Tariq M, Salazar-Marioni S, Khose S, McCullough L, López V,  AbdelKhaleq R, et al. Women with large vessel occlusion acute ischemic stroke are less likely to be routed to comprehensive stroke centers. Journal of Neuro Interventional Surgery 2021; 13: A23-A24.

 43. Mordarska K, Godziejewska-Zawada M. Diabetes in the elderly. Prz Menopauzalny 2017; 16: 38-43.

 44. Lutski M, Zucker I, Shohat T, Tanne D. Characteristics and outcomes of young patients with first-ever ischemic stroke compared to older patients: the National Acute Stroke Israeli Registry. Front Neurol 2017; 8: 421.

 45. Stinear CM, Smith MC, Byblow WD. Prediction tools for stroke rehabilitation. Stroke 2019; 50: 3314-22.

 46. Kang HJ, Stewart R, Park MS, Bae KY, Kim SW, Kim JM, et al. White matter hyperintensities and functional outcomes at 2 weeks and 1 year after stroke. Cerebrovasc Dis 2013; 35: 138-45.

 47. Lerdal A, Gay CL. Acute-phase fatigue predicts limitations with activities of daily living 18 months after first-ever stroke. J Stroke Cerebrovasc Dis 2017 Mar; 26: 523-31.

 48. Gerafi J, Samuelsson H, Viken JI, Blomgren C, Claesson L, Kallio S, et al. Neglect and aphasia in the acute phase as predictors of functional outcome 7 years after ischemic stroke. Eur J Neurol 2017; 24: 1407-15.

 

Rehabilitación en régimen de ingreso en adultos en edad laboral tras un ictus isquémico: análisis clinicofuncional desde una perspectiva de género

Introducción. El papel del género en la independencia funcional en las actividades de la vida diaria tras un ictus isquémico es aún controvertido. Proponemos: a) comparar características clínicas de hombres y mujeres en el momento del ingreso a rehabilitación hospitalaria; b) comparar su independencia funcional en el ingreso y en el alta, y c) identificar predictores de independencia funcional.

Materiales y métodos. Estudio de cohortes retrospectivo observacional. Se incluyeron variables descritas en estudios previos en comparaciones ingreso-alta y en regresión lineal multivariante de la Functional Independence Measure (FIM) en el momento del alta, la ganancia, la eficiencia y la efectividad.

Resultados. Se estudió a 144 pacientes (33%, mujeres) admitidos a rehabilitación en un centro español (≤ 3 semanas tras un ictus isquémico). Los hombres eran mayores (p = 0,003), un 19,6% diabéticos (un 6,4% de las mujeres; p = 0,03) y un 52,6% fumadores (un 72,3% de las mujeres; p = 0,02). No observamos diferencias significativas en la FIM en el momento del ingreso, del alta, la ganancia, la eficiencia ni la efectividad (FIM total, motora ni cognitiva). El análisis de regresión identificó el sexo (beta = –0,13), la gravedad (beta = –0,25) y la FIM total en el momento el ingreso (beta = –0,69) como predictores de la ganancia de la FIM total (R2 = 0,42). Las mismas variables predicen la FIM total en el alta: género (beta = –0,12), gravedad (beta = –0,23) y FIM total en el ingreso (beta = 0,59) (R2 = 0,51). La FIM en el ingreso (beta = –0,64), la gravedad (beta = –0,24), la edad (beta = –0,17) y el tiempo de estancia hospitalaria (beta = –0,45) predicen la eficiencia de la FIM total (R2 = 39,9%). El modelo de efectividad de la FIM explica únicamente el 13,5% de la varianza.

Conclusiones. No encontramos diferencias funcionales entre hombres y mujeres. El sexo es un predictor significativo, pero no explica la mitad de la varianza.
Palabras clave. Actividades de la vida diaria. Género. Isquemia cerebral. Ictus. Rehabilitación. Sexo.

 

© 2022 Revista de Neurología

Si ya es un usuario registrado en Neurologia, introduzca sus datos de inicio de sesión.


Rellene los campos para registrarse en Neurologia.com y acceder a todos nuestros artículos de forma gratuita
Datos básicos
He leído y acepto la política de privacidad y el aviso legal
Seleccione la casilla si desea recibir el número quincenal de Revista de Neurología por correo electrónico. De forma quincenal se le mandará un correo con los títulos de los artículos publicados en Revista de Neurología.
Seleccione la casilla si desea recibir el boletín semanal de Revista de Neurología por correo electrónico. El boletín semanal es una selección de las noticias publicadas diariamente en Revista de Neurología.
Seleccione la casilla si desea recibir información general de neurologia.com (Entrevistas, nuevos cursos de formación, eventos, etc.)
Datos complementarios

Se os solicita los datos de redes para dar repercusión por estos medios a las publicaciones en las que usted participe.

En cumplimiento de la Ley 34/2002, de 11 de julio, de Servicios de la Sociedad de la Información y de Comercio Electrónico (LSSI-CE), EVIDENZE HEALTH ESPAÑA, S.L.U. se compromete a proteger la privacidad de sus datos personales y a no emplearlos para fines no éticos.

El usuario otorga su consentimiento al tratamiento automatizado de los datos incluidos en el formulario, así como a que EVIDENZE HEALTH ESPAÑA S.L.U comparta sus datos con partners, socios y colaboradores comerciales de EVIDENZE que pudieran estar fuera de la Unión Europea, de acuerdo con la información contenida en la política de privacidad del Sitio. Los datos facilitados se tratarán siempre con la máxima confidencialidad, salvaguardando su privacidad.

Usted tiene derecho a rectificar sus datos personales en cualquier momento informándolo a soporte_fmcneuro@neurologia.com. También se le informa de la posibilidad de ejercitar el derecho de cancelación de los datos personales comunicados.



¡CONVIÉRTASE EN USUARIO PREMIUM DE NEUROLOGIA.COM!

Además, por convertirte en usuario premium, recibirá las siguientes ventajas:

  • Plaza asegurada en todos nuestros Másteres (www.ineurocampus.com)
  • Descuento del 5% en los cursos de “Actualización en Neurología”, la FMC que estará disponible próximamente en la web.
  • Descarga gratuita en formato PDF dos de las obras con más éxito publicadas por Viguera Editores:
    • Oromotors Disorders in childhood (M. Roig-Quilis; L. Pennington)
    • Manual de Neuropsicología 2ª ed. (J. Tirapu-Ustárroz; M. Ríos-Lago; F. Maestú)

El precio para hacerse Premium durante el periodo de un año es de 5€, que podrá pagar a continuación a través de una pasarela de pago seguro con tarjeta de crédito, transferencia bancaria o PayPal:

QUIERO HACERME PREMIUM

No deseo hacerme premium


QUIERO MATRICULARME

No deseo matricularme


Estimado usuario de Revista de Neurología,

Debido a la reciente fusión por absorción de VIGUERA EDITORES, S.L.U., la entidad gestora de las publicaciones de Viguera Editores, entre ellas, Revista de Neurología, por EVIDENZE HEALTH ESPAÑA, S.L.U., una de las sociedades también pertenecientes al Grupo Evidenze, y con la finalidad de que Usted pueda seguir disfrutando de los contenidos y distintos boletines a los que está suscrito en la página web de neurologia.com, es imprescindible que revise la nueva política de privacidad y nos confirme la autorización de la cesión de sus datos.

Para dar su consentimiento a seguir recibiendo la revista y los boletines* de neurologia.com vía correo electrónico y confirmar la aceptación de la nueva política de privacidad, así como la cesión de sus datos a Evidenze Health España S.L.U., el resto de las entidades del Grupo Evidenze y sus partners y colaboradores comerciales, incluyendo la posibilidad de llevar a cabo transferencias internacionales a colaboradores extranjeros, pulse en el siguiente enlace:

ACEPTAR

Cancelar

*Los usuarios que no confirmen su aceptación a través del botón dejarán de recibir la revista y los boletines. Le recordamos que puede gestionar sus suscripciones desde el menú “Suscripciones y consentimiento” de la “Zona de Usuario” en la página web www.neurologia.com

Atentamente

El equipo de Revista de Neurología